AP

Merck asks US FDA to authorize promising anti-COVID pill

Oct 10, 2021, 3:02 PM | Updated: Oct 12, 2021, 10:04 am
This undated image provided by Merck & Co. shows their new antiviral medication. The drugmaker has ...

This undated image provided by Merck & Co. shows their new antiviral medication. The drugmaker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. (Merck & Co. via AP)

(Merck & Co. via AP)

WASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic.

If cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat the illness. All other FDA-backed treatments against COVID-19 require an IV or injection.

An antiviral pill that people could take at home to reduce their symptoms and speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals and helping to curb outbreaks in poorer countries with weak health care systems. It would also bolster the two-pronged approach to the pandemic: treatment, by way of medication, and prevention, primarily through vaccinations.

The FDA will scrutinize company data on the safety and effectiveness of the drug, molnupiravir, before rendering a decision.

Merck and its partner Ridgeback Biotherapeutic said they specifically asked the agency to grant emergency use for adults with mild-to-moderate COVID-19 who are at risk for severe disease or hospitalization. That is roughly the way COVID-19 infusion drugs are used.

“The value here is that it’s a pill so you don’t have to deal with the infusion centers and all the factors around that,” said Dr. Nicholas Kartsonis, a senior vice president with Merck’s infectious disease unit. “I think it’s a very powerful tool to add to the toolbox.”

The company reported earlier this month that the pill cut hospitalizations and deaths by half among patients with early symptoms of COVID-19. The results were so strong that independent medical experts monitoring the trial recommended stopping it early.

Side effects were similar between patients who got the drug and those in a testing group who received a dummy pill. But Merck has not publicly detailed the types of problems reported, which will be a key part of the FDA’s review.

Top U.S. health officials continue to push vaccinations as the best way to protect against COVID-19.

“It’s much, much better to prevent yourself from getting infected than to have to treat an infection,” Dr. Anthony Fauci said while discussing Merck’s drug last week.

Still, some 68 million eligible Americans remain unvaccinated, underscoring the need for effective drugs to control future waves of infection.

The prospect of a COVID-19 pill comes amid other encouraging signs: New cases per day in the U.S. have dropped below 100,000 on average for the first time in over two months, and deaths are running at about 1,700 a day, down from more than 2,000 three weeks ago.

Also, the average number of vaccinations dispensed per day has climbed past 1 million, an increase of more than 50% over the past two weeks, driven by the introduction of booster shots and workplace vaccine requirements.

Still, heath authorities are bracing for another possible surge as cold weather drives more people indoors.

Since the beginning of the pandemic, health experts have stressed the need for a convenient pill. The goal is for something similar to Tamiflu, the 20-year-old flu medication that shortens the illness by a day or two and blunts the severity of symptoms like fever, cough and stuffy nose.

Three FDA-authorized antibody drugs have proved highly effective at reducing COVID-19 deaths, but they are expensive, hard to produce and require specialty equipment and health professionals to deliver.

Assuming FDA authorization, the U.S. government has agreed to buy enough of the pills to treat 1.7 million people, at a price of roughly $700 for each course of treatment. That’s less than half the price of the antibody drugs purchased by the U.S. government — over $2,000 per infusion — but still more expensive than many antiviral pills for other conditions.

Merck’s Kartsonis said in an interview that the $700 figure does not represent the final price for the medication.

“We set that price before we had any data, so that’s just one contract,” Kartsonis said. “Obviously we’re going to be responsible about this and make this drug as accessible to as many people around the world as we can.”

Kenilworth, New Jersey-based Merck has said it is in purchase talks with governments around the world and will use a sliding price scale based on each country’s economic means. Also, the company has signed licensing deals with several Indian generic drugmakers to produce low-cost versions of the drug for lower-income countries.

Several other companies, including Pfizer and Roche, are studying similar drugs and are expected to report results in the coming weeks and months. AstraZeneca is also seeking FDA authorization for a long-acting antibody drug intended to provide months of protection for patients who have immune-system disorders and do not adequately respond to vaccination.

Some experts predict various COVID-19 therapies eventually will be prescribed in combination to better protect against the worst effects of the virus.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

AP

Associated Press

US Labor Department warns 3 GOP states over COVID rules

PHOENIX (AP) — The Biden administration threatened Tuesday to revoke the authority for three Republican-controlled states to handle their own workplace safety enforcement because they have refused to adopt rules to protect health care workers from COVID-19. The threats were sent to Arizona, South Carolina and Utah as the U.S. Occupational Safety and Health Administration […]
17 hours ago
FILE - In this Jan. 5, 2017, file photo, Oklahoma state Rep. Kevin West, R-Moore, listens on the fl...
Associated Press

Lawsuit challenges Oklahoma ban on teaching race theory

OKLAHOMA CITY (AP) — A group of Oklahoma students and educators on Tuesday filed a federal lawsuit challenging the constitutionality of a law that bans the teaching of certain concepts of race and racism. The law, HB 1775, also prevents colleges and universities from requiring students to undergo gender or sexual diversity training. The American […]
17 hours ago
Associated Press

21 Chicago cops put on ‘no pay status’ in vaccine standoff

CHICAGO (AP) — Chicago Police Superintendent David Brown said Tuesday that 21 officers have been placed on “no pay status” for refusing to comply with the city’s order to disclose their COVID-19 vaccination status. Brown said that the refusals have not affected staffing. Brown, who disclosed that three members of his own family who he […]
17 hours ago
This Henderson Detention Center booking photo shows entertainer Flavor Flav following his arrest Oc...
Associated Press

Vegas lawyers: 2 sides to Flavor Flav domestic battery case

LAS VEGAS (AP) — Entertainer Flavor Flav will fight a misdemeanor domestic battery charge stemming from a scuffle with his girlfriend at home in suburban Las Vegas, his attorneys said Tuesday. The 62-year-old former rapper, hip-hop and reality TV star, whose legal name is William Jonathan Drayton Jr., was arrested late Oct. 4 after Henderson […]
17 hours ago
FILE - In this Dec. 5, 2017, file photo, Summer Zervos leaves Manhattan Supreme Court at the conclu...
Associated Press

Trump aims to countersue sex assault accuser who sued him

NEW YORK (AP) — Former President Donald Trump wants to countersue a former “Apprentice” contestant who accused him of defaming her when he denied her sexual assault allegations. Saying that Trump is being harassed to keep him from speaking freely, his lawyer asked a court’s permission Monday to pursue a counterclaim against Summer Zervos. The […]
17 hours ago
South Korean army soldiers work to prepare their exercise in Paju, near the border with North Korea...
Associated Press

N Korea confirms missile test designed for submarine launch

SEOUL, South Korea (AP) — North Korea announced Wednesday that it had tested a newly developed missile designed to be launched from a submarine, the first such weapons test in two years and one it says will bolster its military’s underwater operational capability. The test Tuesday was the fifth missile launch since September and came […]
17 hours ago

Sponsored Articles

...

How to Have a Stress-Free Real Estate Experience

The real estate industry has adapted and sellers are taking full advantage of new real estate models. One of which is Every Door Real Estate.
...
IQ Air

How Poor Air Quality Is Affecting Our Future Athletes

You cannot control your child’s breathing environment 100% of the time, but you can make a huge impact.
...
Swedish Health Services

Special Coverage: National Prostate Cancer Awareness Month

There are a wide variety of treatment options available for men with prostate cancer. The most technologically advanced treatment option in the Northwest is Stereotactic Body Radiation Therapy using the CyberKnife platform.
...
Marysville Police Department

Police Opportunities in a Growing, Supportive Washington Community

Marysville PD is looking for both lateral and entry level officers. Begin or continue your career in law enforcement for a growing, supportive community.
...
Comcast

Small, Minority-Owned Businesses in King County and Pierce County Can Now Apply For $10,000 Relief Grants Through Comcast RISE

Businesses in King County and Pierce County can apply beginning on October 1, 2021, at www.ComcastRISE.com for a chance to receive a $10,000 relief grant.
Courtesy of JWatch Photography....
Experience Anacortes

Summer Fun Activities in Anacortes

With minimal travel time required and every activity under the sun, Anacortes is the perfect vacation spot for all ages.
Merck asks US FDA to authorize promising anti-COVID pill